BCL2 and neoplasm: In addition, reverse transcription polymerase chain reaction (RT-PCR) analysis of these tumor samples revealed that the MS67 treatment led to down-regulation of WDR5 target genes such as ribosome subunits and oncogenesis-related transcripts including BCL2 and CSNK1E (Fig. 7F).